May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Potential Binding Partners of Tissue Inhibitor of Metalloproteinase-3
Author Affiliations & Notes
  • P.A. Klenotic
    Ophthamology, Cole Eye Institute, Cleveland, OH, United States
  • J. Qi
    Ophthamology, Cole Eye Institute, Cleveland, OH, United States
  • L.Y. Marmorstein
    Ophthamology, Cole Eye Institute, Cleveland, OH, United States
  • B. Anand-Apte
    Ophthamology, Cole Eye Institute, Cleveland, OH, United States
  • Footnotes
    Commercial Relationships  P.A. Klenotic, None; J. Qi, None; L.Y. Marmorstein, None; B. Anand-Apte, None.
  • Footnotes
    Support  NIH Grant 1R29EY12109
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1423. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P.A. Klenotic, J. Qi, L.Y. Marmorstein, B. Anand-Apte; Potential Binding Partners of Tissue Inhibitor of Metalloproteinase-3 . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1423.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Tissue Inhibitor of Matrix Metalloproteinases-3 (TIMP-3) is a 24kDa protein synthesized by the retinal pigment epithelium and present in Bruch’s membrane. TIMP-3 can inhibit matrix metalloproteinases (MMPs) as well as ADAMs (a-disintegrin and a metalloproteinases domain) and ADAMTSs (ADAM with thrombospondin-like repeats) within the adamalysin family. Mutations of certain cysteine residues to serine result in deposition of excessive amounts of TIMP-3 in Bruch’s membrane, producing early blindness in patients with Sorsby fundus dystrophy. In this study, we proposed to identify potential binding partners of TIMP-3 in the retina. Methods: cDNA inserts of a primary human fetal RPE library were transformed into the yeast reporter strain, AH109, along with a second plasmid for in vivo recombination to generate cDNA-GAL4 activation domain fusion constructs targeted to the nucleus. The complete coding sequence, or the N- or C-terminal domain of human wild type TIMP-3 was used to transform AH109 to generate TIMP-3-GAL4 binding domain fusion constructs. Growth on nutritionally deficient plates denoted an interaction. Sequencing of the clones followed by BLAST searches allowed identification of potential binding partners. Co-transformation and mating experiments confirmed the interactions and ruled out false positives. Results: We have identified 16 clones that appear to be good candidates for putative binding partners of TIMP-3. Binding region has also been determined by using truncated TIMP-3 protein as bait. Some interactions have been confirmed by co-immunoprecipitation experiments in eukaryotic cells systems. Conclusion: Detailed analysis of the interactions of TIMP-3 and potential binding partners will contribute significantly to the understanding of the molecular function of TIMP-3.

Keywords: extracellular matrix • protein structure/function • molecular biology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×